ROBERT CONWAY Insider Trading $ABIO ARCA biopharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT CONWAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT CONWAY. ROBERT CONWAY is Director in ARCA biopharma, Inc. ($ABIO) and CEO in ARRAY BIOPHARMA INC ($ARRY) and CHIEF EXECUTIVE OFFICER in ARRAY BIOPHARMA INC ($ARRY) and Director in Nivalis Therapeutics, Inc. ($NVLS).
ROBERT CONWAY in ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ROBERT CONWAY: Director
Holdings: 50,000 shares
Current Value: $130,000
Latest Transaction: May 13 2021
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT CONWAY in ARCA biopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ABIO, ARRY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 3.19 | 10,000 | 31,947 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Dec 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.16 | 10,000 | 41,630 | 30,000 | 20 K to 30 K (+50.00 %) |
| Sep 25 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.28 | 5,000 | 21,400 | 20,000 | 15 K to 20 K (+33.33 %) |
| Sep 24 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.66 | 3,056 | 14,241 | 15,000 | 11.9 K to 15 K (+25.59 %) |
| Sep 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.77 | 10,000 | 47,660 | 11,944 | 1.9 K to 11.9 K (+514.40 %) |
| Jul 17 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.49 | 10,000 | 24,900 | 35,000 | 25 K to 35 K (+40.00 %) |
| Mar 27 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.59 | 25,000 | 64,750 | 25,000 | 0 to 25 K |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 |
Page: 1